Compile Data Set for Download or QSAR
Report error Found 37 for UniProtKB: P01562
LigandPNGBDBM622955(US11780842, Compound 17 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 500nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622954(US11780842, Compound 16 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 500nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622949((13E,14E)-17-(methylamino)-4-oxa-2,7-diaza-1(5,3)-...)
Affinity DataIC50: 500nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622949((13E,14E)-17-(methylamino)-4-oxa-2,7-diaza-1(5,3)-...)
Affinity DataIC50: 500nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622951(US11780842, Compound 13 | (13E,14E)-4,4-dimethyl-1...)
Affinity DataIC50: 500nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622949((13E,14E)-17-(methylamino)-4-oxa-2,7-diaza-1(5,3)-...)
Affinity DataIC50: 500nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622961(US11780842, Compound 23 | (13E,14E)-34-chloro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622957(US11780842, Compound 19 | (13E,14E)-35-fluoro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622958(US11780842, Compound 20 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622959(US11780842, Compound 21 | (13E,14E)-34-fluoro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622960(US11780842, Compound 22 | (13E,14E)-36-fluoro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622971(US11780842, Compound 33 | (13E,14E)-35-chloro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622956(US11780842, Compound 24 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622963(US11780842, Compound 25 | (13E,14E)-6-methyl-17- (...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622964(US11780842, Compound 26 | (13E,14E)-35-methyl-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622965(US11780842, Compound 27 | (13E,14E)-34,36-dichloro...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622966(US11780842, Compound 28 | (13E,14E)-34,35-difluoro...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622967(US11780842, Compound 29 | (15E,14E)-34,36-difluoro...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622968(US11780842, Compound 30 | (13E,14E)-5-methyl-17- (...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622969(US11780842, Compound 31 | (13E,14E)-34-methoxy-17-...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622970(US11780842, Compound 32 | (13E,14E)-35-fluoro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622972(US11780842, Compound 34 | (13E,14E)-34-fluoro-17- ...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622956(US11780842, Compound 24 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622950(US11780842, Compound 12)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622974(US11780842, Compound 36 | (13E,14E)-6-methyl-17- (...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622973(US11780842, Compound 35 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 550nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622985(US11780842, Compound 47 | (13E,14E,34E)-17-(methyl...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622984(US11780842, Compound 46 | (13E,14E)-35-fluoro-17- ...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622983(US11780842, Compound 45 | (13E,14E,34E)-17-(methyl...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622982(US11780842, Compound 44 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622981(US11780842, Compound 43 | (12Z,33E,34E)-37-(methyl...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622980(US11780842, Compound 42 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622979(US11780842, Compound 41 | (13E,14E)-17-(methylamin...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622978(US11780842, Compound 40 | (13E,14E)-35-methoxy-17-...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622977(US11780842, Compound 39 | (13E,14E)-36-fluoro-34-m...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622976(US11780842, Compound 38 | (13E,14E)-35-hydroxy-17-...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM622975(US11780842, Compound 37 | (13E,14E)-5-methyl-17- (...)
Affinity DataIC50: 5.50E+3nMAssay Description:10 mM test compound stock or 1 mM control compound stock (tofocitinib, ruxolitinib or staurosporine) in DMSO was diluted to 0.4 mM in DMSO. A 3-fold ...More data for this Ligand-Target Pair
In DepthDetails
US Patent